Ontology highlight
ABSTRACT: Background
Aspirin as a primary preventative in healthy older adults did not prolong disability-free survival in the ASPREE randomized trial. Observational studies following randomized trials allow assessment of benefits and harms which may not appear during the trial. We describe health characteristics, physical function, and aspirin use in the ASPREE-eXTension (ASPREE-XT) observational study cohort.Methods
Descriptive statistics compared health characteristics of those consented to ASPREE-XT at their first post-trial baseline (XT01) to corresponding ASPREE baseline values, and to those not consented. Likelihood of an indication for aspirin was assessed in participants reporting aspirin use at XT01.Results
16,317 (93%) of the remaining and eligible 17,546 ASPREE pa
SUBMITTER: Ernst ME
PROVIDER: S-EPMC10330669 | biostudies-literature | 2023 Jul
REPOSITORIES: biostudies-literature